Sign in to view content

The Functional Burden of Diabetic Retinopathy in the United States – How Ranibizumab May Shift Treatment Paradigms

Jeffrey R Willis, MD/PhD

Video
Published 2017

Related

Characteristics and the Need for Supplementation Following 0.19mg Fluocinolone Acetonide (FAc) in Diabetic Macular Edema (DME) Patients
Victor Hugo Gonzalez, MD
Annual Meeting Talks
2021
Clinical Outcomes of Eyes with Diabetic Macular Edema Switched from Aflibercept to Ranibizumab Therapy
Michael A Klufas, MD
On Demand Cases, Courses, and Papers
2019
Two years visual acuity and anatomical outcomes of patients with diabetic macular oedema treated with intravitreal aflibercept in a real life setting
Marko Lukic, MD PhD FEBO FASRS
On Demand Cases, Courses, and Papers
2019

Category: Diabetic Retinopathy

See more